CTLA4 and myocarditis: Different types of ICIs vary in their risk of inducing myocarditis: PD-1 or PD-L1 inhibitors alone can cause myocarditis, but the risk is significantly higher with combination therapy involving PD-1/PD-L1 and CTLA-4 inhibitors.